Related Experiment Video
Updated: Dec 31, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular
Yingxia Yang1,2, Gang Yin1, Yong Jiang3,4
1Department of Magnetic Resonance Imaging, Fuwai Hospital and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.
Insights
Patients with non-obstructive hypertrophic cardiomyopathy (NOHCM) exhibit impaired left atrial (LA) reservoir and conduit function, even before LA enlargement. Cardiovascular magnetic resonance feature tracking (CMR-FT) can detect this early LA dysfunction.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Cardiac MRI
Background:
- Atrial fibrillation (AF) is a common complication in hypertrophic cardiomyopathy (HCM), linked to adverse outcomes.
- While left atrial (LA) diameter predicts AF in HCM, the role of LA dysfunction remains unclear.
- Non-obstructive HCM (NOHCM) is a specific subtype where early functional changes may precede structural alterations.
Purpose of the Study:
- To evaluate left atrial (LA) function in patients with non-obstructive hypertrophic cardiomyopathy (NOHCM) using cardiovascular magnetic resonance feature tracking (CMR-FT).
- To identify early signs of LA dysfunction in NOHCM patients.
- To compare LA function between NOHCM patients and healthy controls.
Main Methods:
- Thirty-three NOHCM patients and 28 healthy controls underwent cardiovascular magnetic resonance (CMR).
- CMR feature tracking (CMR-FT) was used to quantitatively analyze global and regional LA function, including reservoir, conduit, and booster pump functions.
- LA strain and strain rate parameters were measured in 6 myocardial segments.
Main Results:
- NOHCM patients showed significantly impaired LA reservoir and conduit function compared to controls.
- LA booster pump function was preserved in NOHCM patients.
- Regional analysis revealed decreased strain and strain rate in specific LA segments (inferior, septal-roof, antero-roof) in NOHCM patients.
Conclusions:
- Patients with NOHCM exhibit impaired LA reservoir and conduit function, along with regional LA deformation, occurring before LA enlargement.
- CMR-FT is effective in identifying early-stage LA dysfunction and deformation in NOHCM.
- These findings highlight the potential of CMR-FT to detect subtle functional changes preceding structural remodeling in HCM.
Background:
Atrial fibrillation (AF) is the most common arrhythmia in hypertrophic cardiomyopathy (HCM) and is associated with adverse outcomes in HCM patients. Although the left atrial (LA) diameter has consistently been identified as a strong predictor of AF in HCM patients, the relationship between LA dysfunction and AF still remains unclear. The aim of this study is to evaluate the LA function in patients with non-obstructive HCM (NOHCM) utilizing cardiovascular magnetic resonance feature tracking (CMR-FT).
Methods:
Thirty-three patients with NOHCM and 28 healthy controls were studied. The global and regional LA function and left ventricular (LV) function were compared between the two groups. The following LA global functional parameters were quantitively analyzed: reservoir function (total ejection fraction [LA total EF], total strain [εs], peak positive strain rate [SRs]), conduit function (passive ejection fraction [LA passive EF], passive strain [εe], peak early-negative SR [SRe]), and booster pump function (active ejection fraction [LA active EF], active strain [εa], peak late-negative SR [SRa]). The LA wall was automatically divided into 6 segments: anterior, antero-roof, inferior, septal, septal-roof and lateral. Three LA strain parameters (εs, εe, εa) and their corresponding strain rate parameters (SRs, SRe, SRa) during the reservoir, conduit and booster pump LA phases were segmentally measured and analyzed.
Results:
The LA reservoir (LA total EF: 57.6 ± 8.2% vs. 63.9 ± 6.4%, p < 0.01; εs: 35.0 ± 12.0% vs. 41.5 ± 11.2%, p = 0.03; SRs: 1.3 ± 0.4 s- 1 vs. 1.5 ± 0.4 s- 1, p = 0.02) and conduit function (LA passive EF: 28.7 ± 9.1% vs. 37.1 ± 10.0%, p < 0.01; εe: 18.7 ± 7.9% vs. 25.9 ± 10.0%, p < 0.01; SRe: - 0.8 ± 0.3 s- 1 vs. -1.1 ± 0.4 s- 1, p < 0.01) were all impaired in patients with NOHCM when compared with healthy controls, while LA booster pump function was preserved. The LA segmental strain and strain rate analysis demonstrated that the εs, εe, SRe of inferior, SRs, SRe of septal-roof, and SRa of antero-roof walls (all p < 0.05) were all decreased in the NOHCM cohort. Correlations between LA functional parameters and LV conventional function and LA functional parameters and baseline parameters (age, body surface area and NYHA classification) were weak. The two strongest relations were between εs and LA total EF(r = 0.84, p < 0.01), εa and LA active EF (r = 0.83, p < 0.01).
Conclusions:
Compared with healthy controls, patients with NOHCM have LA reservoir and conduit dysfunction, and regional LA deformation before LA enlargement. CMR-FT identifies LA dysfunction and deformation at an early stage.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests

